User Reviews for Lymphoseek
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care. Learn more about Lymphoseek.
Reviews for Lymphoseek
For Diagnosis and Investigation "Conduced first exploratory use in June, 2013 indication cutaneous melanoma, Breslow/3mm. Tilmanocept was well received by the patient with no local. Clearance delay provision <20 min. SLN discovery total <4 min/2 SLN/Path."
B Anderson, MD (taken for less than 1 month) June 27, 2013
85 users found this comment helpful.
More about Lymphoseek (tilmanocept)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 1 Review – Add your own review/rating
- Drug class: radiologic conjugating agents